Related references
Note: Only part of the references are listed.Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer A Randomized Clinical Trial
Michelle E. Melisko et al.
JAMA ONCOLOGY (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy
Elisabeth Sulaica et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
Carolyn D. Runowicz et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
A Practical Solution for Dyspareunia in Breast Cancer Survivors: A Randomized Controlled Trial
Martha F. Goetsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (GynoflorA®) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study
Gilbert Donders et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Locating Pain in Breast Cancer Survivors Experiencing Dyspareunia A Randomized Controlled Trial
Martha F. Goetsch et al.
OBSTETRICS AND GYNECOLOGY (2014)
Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2013)
Effects of Vaginal Estrogens on Serum Estradiol Levels in Postmenopausal Breast Cancer Survivors and Women at Risk of Breast Cancer Taking an Aromatase Inhibitor or a Selective Estrogen Receptor Modulator
Shannon Wills et al.
JOURNAL OF ONCOLOGY PRACTICE (2012)
Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients
G. Pfeiler et al.
CLIMACTERIC (2011)
Comparison of Liquid Chromatography-Tandem Mass Spectrometry, RIA, and ELISA Methods for Measurement of Urinary Estrogens
Jessica M. Faupel-Badger et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors
A Kendall et al.
ANNALS OF ONCOLOGY (2006)
Drug therapy: Aromatase inhibitors in breast cancer
IE Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
